Replies to post #105 on Cumberland Pharmaceuticals, Inc. (CPIX)

[tw0122]

Reversing tapping 3 year highs $2.90s + 26% still small floater

[georgie18]

CPIX...$2.77...🥳...Hit $3.93 on the Channel Breakout...

georgie18

Member Level
Re: georgie18 post# 103

Wednesday, December 18, 2024 2:05:56 PM

Post#
105
of 107
CPIX...$2.33...Trying to Reverse here...🥳

georgie18

Member Level
Re: georgie18 post# 667357

Tuesday, December 10, 2024 8:16:14 AM

Post#
667359
of 668190
CPIX...$3.07...🥳...Off my $2.15 Alert...

georgie18

Member Level
Re: georgie18 post# 97

Tuesday, December 10, 2024 8:12:33 AM

Post#
102
of 102
CPIX...$2.71...🥳...Off my $2.15 Alert...

georgie18

Member Level
Re: georgie18 post# 667334

Monday, December 09, 2024 4:26:19 PM

Post#
667337
of 667357
CPIX...$2.27...🥳

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:19:53 PM

Post#
96
of 96
CPIX...$2.15...🥳...NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a supplemental New Drug Application (sNDA) for its Acetadote® (N-acetylcysteine for injection) product. Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen1.